Stephan Buchmann

Promotion of sleep by targeting the orexin system in rats, dogs and humans

Catherine Brisbare‐Roch, Jasper Dingemanse, Ralf Koberstein et al. · Nature Medicine · 2007 · 567 citations

Life Sciences, Neurobiology, Neuroscience +12

Pharmacology of Macitentan, an Orally Active Tissue-Targeting Dual Endothelin Receptor Antagonist

Marc Iglarz, Christoph A. Binkert, Keith Morrison et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 325 citations

Medicine, Medicinal Chemistry, Pharmacology +10

2-Imino-thiazolidin-4-one Derivatives as Potent, Orally Active S1P₁Receptor Agonists

Martin H. Bolli, Stefan Abele, Christoph A. Binkert et al. · Journal of Medicinal Chemistry · 2010 · 178 citations · Full text

Medicine, Immunology, Pharmacology +17

The Discovery of <i>N</i>-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-<i>N</i>′-propylsulfamide (Macitentan), an Orally Active, Potent Dual Endothelin Receptor Antagonist

Martin H. Bolli, Christoph Boss, Christoph A. Binkert et al. · Journal of Medicinal Chemistry · 2012 · 148 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Novel Benzo[1,4]diazepin-2-one Derivatives as Endothelin Receptor Antagonists

Martin H. Bolli, Judith Marfurt, Corinna Grisostomi et al. · Journal of Medicinal Chemistry · 2004 · 77 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12